Envoy Medical Announces Reverse Stock Split
Envoy Medical announced a 1-for-10 reverse stock split of its Class A common stock, effective at market open on October 26, 2026, with the stock continuing to trade under COCH on Nasdaq. The company stated the split is intended to maintain compliance with Nasdaq's $1.00 minimum bid price requirement and may improve per-share pricing to broaden institutional eligibility. Warrants, convertible securities, and equity-plan shares will be proportionately adjusted; fractional shares will be paid in cash.
Key figures
- Effective date
- 2026-10-26
- Reverse split ratio
- 1-for-10
- Minimum bid price requirement
- $1.00
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.